Seth Rice

404 total citations
12 papers, 298 citations indexed

About

Seth Rice is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Seth Rice has authored 12 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Seth Rice's work include Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antibiotic Resistance in Bacteria (3 papers). Seth Rice is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antibiotic Resistance in Bacteria (3 papers). Seth Rice collaborates with scholars based in United States, Colombia and Spain. Seth Rice's co-authors include Kyle Stamper, Razieh Kebriaei, Michael J. Rybak, Mariana Castanheira, César A. Arias, Truc T. Tran, Jordan R. Smith, An Q Dinh, Kavindra V. Singh and Barbara E. Murray and has published in prestigious journals such as Cancer Research, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Seth Rice

12 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seth Rice United States	10	141	121	101	87	64	12	298
Huoyang Lv China	9	170 1.2×	69 0.6×	63 0.6×	56 0.6×	64 1.0×	18	350
Simeng Duan China	12	107 0.8×	138 1.1×	65 0.6×	134 1.5×	62 1.0×	19	308
Timothy M. Murphy United States	6	186 1.3×	138 1.1×	128 1.3×	75 0.9×	72 1.1×	8	317
Yoko Takayama Japan	9	128 0.9×	107 0.9×	46 0.5×	100 1.1×	49 0.8×	42	348
Samira M. Hamed Egypt	11	194 1.4×	90 0.7×	48 0.5×	75 0.9×	34 0.5×	20	393
Keren Shi China	13	368 2.6×	135 1.1×	92 0.9×	128 1.5×	71 1.1×	19	491
Viktoria Eirini Mavromanolaki Greece	9	129 0.9×	77 0.6×	60 0.6×	169 1.9×	44 0.7×	28	341
Bing Bai China	9	145 1.0×	111 0.9×	33 0.3×	65 0.7×	81 1.3×	14	327
Dimitra Stafylaki Greece	9	97 0.7×	79 0.7×	59 0.6×	111 1.3×	48 0.8×	31	271
Wenjian Liao China	13	323 2.3×	148 1.2×	80 0.8×	102 1.2×	62 1.0×	23	534

Countries citing papers authored by Seth Rice

Since Specialization

Citations

This map shows the geographic impact of Seth Rice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Rice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Rice more than expected).

Fields of papers citing papers by Seth Rice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth Rice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Rice. The network helps show where Seth Rice may publish in the future.

Co-authorship network of co-authors of Seth Rice

This figure shows the co-authorship network connecting the top 25 collaborators of Seth Rice. A scholar is included among the top collaborators of Seth Rice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth Rice. Seth Rice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Abrisqueta, Pau, Reinhard Marks, Irit Avivi, et al.. (2024). Abstract CT174: A phase 1 study of JBH492, an anti C-C chemokine receptor 7 antibody-drug conjugate (anti-CCR7 ADC), assessing safety and efficacy in lymphoid malignancies. Cancer Research. 84(7_Supplement). CT174–CT174. 3 indexed citations

Kebriaei, Razieh, Kyle Stamper, Kavindra V. Singh, et al.. (2020). Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium. The Journal of Infectious Diseases. 222(9). 1531–1539. 12 indexed citations

Kebriaei, Razieh, et al.. (2020). Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights. Journal of Antimicrobial Chemotherapy. 75(10). 2894–2901. 10 indexed citations

Kebriaei, Razieh, Seth Rice, Kyle Stamper, et al.. (2019). Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis /oralis in an Ex Vivo Simulated Endocarditis Vegetation Model. Antimicrobial Agents and Chemotherapy. 63(6). 13 indexed citations

Kebriaei, Razieh, et al.. (2019). Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 63(8). 130 indexed citations

Kebriaei, Razieh, Kyle Stamper, Seth Rice, et al.. (2019). 1546. Efficacy of Daptomycin Combinations Against Daptomycin-Resistant Enterococcus faecium Differs by β-lactam. Open Forum Infectious Diseases. 6(Supplement_2). S564–S564. 1 indexed citations

Kebriaei, Razieh, Seth Rice, Kyle Stamper, & Michael J. Rybak. (2019). Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model. Antimicrobial Agents and Chemotherapy. 63(4). 20 indexed citations

Smith, Jordan R., et al.. (2018). Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 74(1). 82–86. 18 indexed citations

Kebriaei, Razieh, Seth Rice, Kavindra V. Singh, et al.. (2018). Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions. Antimicrobial Agents and Chemotherapy. 62(8). 36 indexed citations

10.

Bhise, Ketki, Samaresh Sau, Razieh Kebriaei, et al.. (2018). Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA. Materials. 11(7). 1245–1245. 23 indexed citations

11.

Smith, Jordan R., Juwon Yim, Seth Rice, et al.. (2018). Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations. Antimicrobial Agents and Chemotherapy. 62(5). 15 indexed citations

12.

Yim, Juwon, Jordan R. Smith, Seth Rice, et al.. (2017). Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs). Journal of Antimicrobial Chemotherapy. 72(8). 2290–2296. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact